Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
Emerging Infectious Diseases|October 18, 2011
Extensively drug-resistant tuberculosis in women, KwaZulu-Natal, South AfricaMax R O'Donnell, Jennifer Zelnick, Lise Werner, et al.PLOS Global Public Health|March 24, 2023
A scoping review of patient-centred tuberculosis care interventions: Gaps and opportunitiesHanlie Myburgh, Dzunisani Baloyi, Marian Loveday, et al.British Journal of Clinical Pharmacology|May 8, 2022
Bedaquiline exposure in pregnancy and breastfeeding in women with rifampicin-resistant tuberculosisRichard Court, Kamunkhwala Gausi, Buyisile Mkhize, et al.Journal of Midwifery & Women'S Health|July 3, 2007
Community-based situation analysis of maternal and neonatal care in South Africa to explore factors that impact utilization of maternal health servicesPulani Tlebere, Debra Jackson, Marian Loveday, et al.Plos One|April 11, 2014
Association between health systems performance and treatment outcomes in patients co-infected with MDR-TB and HIV in KwaZulu-Natal, South Africa: implications for TB programmesMarian Loveday, Nesri Padayatchi, Kristina Wallengren, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2016
Implementation and Operational Research: Clinical Impact of the Xpert MTB/RIF Assay in Patients With Multidrug-Resistant TuberculosisNesri Padayatchi, Naressa Naidu, Nonhlanhla Yende-Zuma, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2020
Maternal and Infant Outcomes Among Pregnant Women Treated for Multidrug/Rifampicin-Resistant Tuberculosis in South AfricaMarian Loveday, Jennifer Hughes, Babu Sunkari, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 10, 2022
Validation and application of a quantitative LC-MS/MS assay for the analysis of first-line anti-tuberculosis drugs, rifabutin and their metabolites in human breast milkPhiwe Zuma, Anton Joubert, Marthinus van der Merwe, et al.Plos One|June 1, 2013
A pilot study of an mHealth application for healthcare workers: poor uptake despite high reported acceptability at a rural South African community-based MDR-TB treatment programKrisda H Chaiyachati, Marian Loveday, Stephen Lorenz, et al.British Journal of Clinical Pharmacology|December 2, 2025
Population pharmacokinetics of levofloxacin in breastmilk in patients with rifampicin-resistant tuberculosisSharon Sawe, Lufina Tsirizani, Buyisile Mkhize, et al.Pageof 6